Adverum Biotechnologies, Inc.
NASDAQ:ADVM
8 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -117.165 | -154.536 | -145.54 | -117.507 | -64.486 | -72.627 | -56.147 | -113.747 | -47.453 | -25.404 | -5.276 | -1.811 |
| Depreciation & Amortization
| 5.644 | 6.528 | 4.645 | 4.158 | 1.573 | 1.75 | 2.096 | 1.603 | 0.812 | 0.162 | 0.026 | 0.001 |
| Deferred Income Tax
| 0.369 | 0 | 3.833 | 0.863 | -1.273 | -1.25 | 0.593 | 60.714 | 0.801 | 0.963 | 1.745 | -0.019 |
| Stock Based Compensation
| 17.569 | 20.079 | 25.194 | 20.391 | 9.899 | 13.432 | 8.723 | 11.416 | 11.505 | 8.567 | 0.515 | 0.076 |
| Change In Working Capital
| -8.317 | 19.889 | 4.062 | 12.729 | 5.059 | -1.621 | -0.756 | 1.64 | -1.221 | 10.046 | -0.07 | 0.47 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0.886 | -0.437 | -0.006 | 0.008 | -0.007 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | -0.029 | -1.107 | 1.203 | 2.287 | -0.357 | 0 |
| Accounts Payables
| -0.369 | 0.845 | -1.612 | 1.585 | -0.65 | -0.067 | 0.333 | -0.111 | -0.312 | -0.006 | 0.286 | 0.445 |
| Other Working Capital
| -7.948 | 19.044 | 5.674 | 11.144 | 5.709 | -1.554 | -1.946 | 3.295 | -2.106 | 7.757 | 0.008 | 0.025 |
| Other Non Cash Items
| 10.578 | -0.051 | -0.025 | 0.075 | 0.058 | 6.352 | 0.07 | 0.008 | 0.218 | 0.018 | 0.885 | 0.016 |
| Operating Cash Flow
| -91.322 | -108.091 | -107.831 | -79.291 | -49.17 | -53.964 | -45.421 | -38.366 | -35.338 | -5.648 | -2.175 | -1.267 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.808 | -11.816 | -15.123 | -11.844 | -19.247 | -0.809 | -1.016 | -2.412 | -2.992 | -0.943 | -0.091 | -0.003 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.449 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -36.718 | -104.363 | -407.514 | -570.386 | -197.343 | -78.726 | -209.787 | -38.775 | -88.427 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 134.401 | 257.899 | 501.346 | 302.063 | 148.517 | 148.979 | 88.599 | 37.738 | 49.85 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38.775 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 96.875 | 141.72 | 78.709 | -280.167 | -68.073 | 69.444 | -122.204 | 38.775 | -41.569 | -0.943 | -0.091 | -0.003 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | -13.607 | -0.24 | -0.061 | -0.112 | -0.175 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.489 | 0.003 | 2.637 | 344.302 | 25.889 | 70.187 | 16.519 | 0.949 | 138.954 | 116.453 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.42 | 14.211 | 0.712 | 11.744 | 2.414 | -0.063 | 0.229 | 0.556 | -0.094 | 52.989 | 2.48 | 0.5 |
| Financing Cash Flow
| 0.489 | 0.607 | 2.397 | 355.985 | 28.191 | 69.949 | 16.748 | 0.556 | 138.86 | 165.442 | 2.48 | 0.5 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0.527 | 0 | 0 | 0 | 0 | 0 | -0.774 | -0.143 | -0.009 | -0.011 | -0.007 | 0.009 |
| Net Change In Cash
| 6.569 | 34.236 | -26.725 | -3.473 | -89.052 | 85.429 | -151.651 | 0.822 | 61.944 | 158.84 | 0.207 | -0.761 |
| Cash At End Of Period
| 75 | 70.934 | 36.698 | 63.423 | 66.896 | 155.948 | 70.519 | 222.17 | 221.348 | 159.404 | 0.564 | 0.357 |